A cyclooxygenase-2 inhibitor reduces serum prostatic-specific antigen levels in men with benign prostatic hyperplasia and lower urinary tract symptoms and helps differentiate chronic inflammation from prostate cancer
- Resource Type
- Short Communication
- Source
- In
Tzu Chi Medical Journal 2011 23(1):32-33 - Subject
- Language
- ISSN
- 1016-3190